Table 2.
Participant clinical characteristics
| Glaucoma (n = 18) | Retinitis Pigmentosa (n = 19) | |
|---|---|---|
| Visual acuity (better eye) | ||
| Median | 20/27.5 | 20/40 |
| Range | 20/20–20/150 | 20/20–20/800 |
| Visual fielda | ||
| Median | −16.05 dB | 10° |
| Range | −31.42- -9.86 dB | 4–20º |
| Pelli-Robson contrast sensitivity (log contrast sensitivity) | ||
| Median | 1.1 | 1.2 |
| Range | 0.5–1.5 | 0.00–1.7 |
| Duration of disease (years) | ||
| Median | 10 | 26 |
| Range | 1–22 | 3–61 |
| Other ocular comorbidity | ||
| Cataract | 89% | 58% |
| Usher Syndrome | 0% | 26% |
| Other | 6% | 11% |
| Medical comorbidity | ||
| Yes | 94% | 53% |
| Depression or anxiety | 22% | 32% |
| Hypertension | 61% | 0% |
| Heart Disease | 22% | 0% |
| Stroke | 11% | 0% |
| Diabetes | 28% | 0% |
| Lung Disease | 22% | 0% |
| Arthritis | 39% | 0% |
| Other | 28% | 21% |
| Low vision device use | ||
| Yes | 50% | 84% |
| Low vision rehabilitation experience | ||
| Yes | 39% | 63% |
dB: decibel, RP retinitis pigmentosa
a For glaucoma: visual field mean deviation in decibels; for RP widest diameter of III4e isopter on Goldmann visual field test